Vanda Pharmaceuticals Inc.
METHODS FOR THE ADMINISTRATION OF ILOPERIDONE

Last updated:

Abstract:

The present invention relates to methods for the identification of genetic polymorphisms that may be associated with a risk for QT prolongation after treatment with iloperidone and related methods of administering iloperidone to patients with such polymorphisms.

Status:
Application
Type:

Utility

Filling date:

8 Apr 2022

Issue date:

18 Aug 2022